Tadalafil: Uses, Dosage, and Side Effects You Should Know

From online ED medication sellers to major e-commerce platforms, everyone is getting in on the ED med game. However, it’s important to understand what represents tried and true, gold standard treatment and what may be hyped to sell a more expensive product. One such question revolves around a relatively new phenomenon – combining Tadalafil, the generic of Cialis, and sildenafil, the generic of Viagra, into a single-dose tablet, chewable, or sublingual tab. If you search online, many ED med sellers are now touting this as an effective alternative to single medication therapy. The short answer is that both sildenafil and tadalafil are phosphodiesterase-5 (PDE-5) inhibitors and work similarly.

• Tadalafil 40mg has a longer duration of action compared to some ED drugs.
• The medication can be taken with or without food, based on personal preference.
• Seek immediate medical help if you experience an erection lasting over 4 hours.
• Tadalafil 40mg might interact with certain antifungal or antibiotic drugs.
• Dose adjustments are necessary for patients with certain health conditions.
• Always check for drug interactions before starting Tadalafil 40mg.

To that end, it’s unlikely there will be any substantial difference between a single and dual medication therapy. From a urologist’s perspective, the dual medication option is a slick marketing tool to introduce a new medication option while creating a compoundable option that circumvents the limitations associated with marketing and selling generic drugs. While most patients will not have adverse effects with an appropriate combination of medical therapy, there can be potential concerns. For sildenafil, the max dose is 100 mg, while tadalafil’s max dose is 20 mg. It’s vital that, in combination, these two drugs do not cause patients to overdose. With different dosages and time of action, knowing precisely what proportion of each medication should be taken can be challenging. Some unscrupulous compounding pharmacies and online purveyors may not regulate how much of each drug they use.

Tadalafil While Breastfeeding

PDE5 is important in regulating intracellular concentrations of cGMP by catalyzing its hydrolysis and inactivating cGMP. The inhibition of PDE5 by tadalafil increases the cGMP level in the corpus cavernosum. As a result, prolonged smooth muscle relaxation occurs together with vasodilation of the corpus cavernosum, leading to penile erection (Carrier, 2003). Tadalafil has no effect in the absence of sexual stimulation. In addition, tadalafil is also used to treat benign prostatic hyperplasia (BPH) and pulmonary arterial hypertension (Croxtall and Lyseng-Williamson, 2010).

More common

Tadalafil preserves the concentration of cGMP, thus promoting vasodilation in corpus cavernosum and pulmonary vasculature. Tadalafil is rapidly absorbed after oral administration. Compared with other PDE5 inhibitors used in treating erectile dysfunction, tadalafil has the longest duration of action, making it the only once-daily agent of all PDE5 inhibitors. Tadalafil is a phosphodiesterase-5 (PDE-5) inhibitor that was tadalafil over the counter uk approved by the US Food and Drug Administration (FDA) in 2009 for the treatment of pulmonary arterial hypertension (PAH). The purpose of this review is to evaluate the pharmacology, pharmacokinetic properties, clinical efficacy, adverse effects, drug interactions, and dosage and administration of tadalafil in patients with PAH.

Tadalafil for Pulmonary Arterial Hypertension (PAH)

A literature search of MEDLINE and International Pharmaceutical Abstracts (1960 through September 5, 2010) was conducted with the search terms tadalafil, pulmonary arterial hypertension, and phosphodiesterase-5 inhibitor. Data found from orignial research and case series published in English were screened for relevancy to pharmacology, pharmacokinetics, clinical efficacy and safety, and tolerability. Relevant articles from the bibliographies of the identified published articles were also obtained. Unpublished data and posters were obtained from the manufacturer of tadalafil and the FDA Web site. By selectively inhibiting PDE-5, tadalafil causes nitric oxide–mediated vasodilation in the pulmonary vasculature. A second practical consideration for most patients is that each drug has a somewhat different side effect profile.

• Tadalafil 40mg is sometimes used off-label for other medical conditions.
• Keep a record of your medication intake and any side effects.
• Do not share Tadalafil 40mg with others, even if they have similar symptoms.
• Tadalafil 40mg can be part of a comprehensive ED treatment plan.
• Follow prescribed dosing strictly to avoid adverse effects.
• Avoid driving or operating machinery if feeling dizzy after taking Tadalafil 40mg.

By taking a combination of drugs, patients are increasing their risk of experiencing a side effect – they are now subjected to the risk profile of two drugs rather than just one. Combination drug therapy tends to be more expensive than standard generic tablets. Most patients will be better suited to try one drug for a couple of weeks and then switch to the other for another couple of weeks to see which has a better function and side effect profile.

From then on, patients can enjoy the low cost of generic tablets while still getting the same benefit. Marketing ED medications and various formulations and options is a billion-dollar business with plenty of misunderstandings that must be corrected. Ultimately, patients should speak to a qualified men’s health urologist to understand more about the cause of their ED and their best treatment options.

Newfangled ED medication options like combination therapy may be marketed as effective, but ultimately, they may be a waste of money. We encourage you to contact tadalafil daily our office to learn more. Tadalafil is defined as an oral PDE-5 inhibitor that has a longer half-life than sildenafil, allowing for once daily administration. It is used in the treatment of conditions such as pulmonary arterial hypertension, showing small improvements in portal venous and pulmonary artery pressures. Tadalafil is a newer, longer-acting PDE5 inhibitor. A recent 16-week RCT included patients with IPAH and PAH associated with connective tissue disease, congenital heart disease, and HIV who were randomized to placebo or tadalafil 2.5 mg, 10 mg, 20 mg, or 40 mg orally once daily.46 Treatment was given as monotherapy, or, in 53% of patients, as add-on therapy to bosentan. Tadalafil 40 mg increased 6-minute walk distance and quality of life, delayed the time to clinical worsening, and improved hemodynamics. The most common treatment-related adverse event reported with tadalafil was headache.

Key takeaways about tadalafil

Tadalafil is an oral PDE-5 inhibitor with longer half-life than sildenafil so that it requires once daily administration. To date, only one case describing treatment of PoPH has been reported that showed a small improvement in portal venous and pulmonary artery pressures [67]. We believe that the role for tadalafil in the treatment of PoPH is similar to that of sildenafil. In a single randomized placebo-controlled study 10 HAPE-susceptible subjects received tadalafil 10 mg twice daily during a rapid ascent to 4559 m [86]. Two of the subjects receiving tadalafil withdrew from the study due to severe AMS on arrival at 4559 m, although they did not have HAPE prior to descent.

Tadalafil for Erectile Dysfunction (ED)

Only 1 of the remaining 8 subjects who received tadalafil developed HAPE. In the placebo group, 7 of 9 subjects developed HAPE. The occurrence of AMS with tadalifil may have discouraged further trials as well as the accumulation of any clinical experience using tadalafil in the prevention of HAPE. Tadalafil cannot be recommended to prevent HAPE in the absence of further study. Tadalafil is a selective PDE5-inhibitor that can be administered once daily.

Less Common Tadalafil Side Effects (Occurring in 1 in 100 people)

Its beneficial effects in adults with PAH, consisting of improved exercise capacity, haemodynamics and time to clinical worsening, have been demonstrated in a recent pivotal RCT (PHIRST-1). Patients were at least 12 years old, however the median age was 54 ± 15 years. Tadalafil was well tolerated, side-effects reported were headache, myalgia and flushing.53 No specific data concerning tadalafil in children with PAH are available. Tadalafil, a carboline derivative with vasodilatory activity, selectively inhibits cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). During sexual stimulation, nitric oxide (NO) produced and released from nerves and endothelial cells, stimulates soluble guanylate cyclase and initiates the production of the messenger cGMP in the corpus cavernosum smooth muscles. Tadalafil is a once daily dispensed, selective PDE-5i. An RCT (PHIRST [Pulmonary arterial Hypertension and ReSponse to Tadalafil] trial) in 406 PAH patients (53% on background bosentan therapy) treated with tadalafil 2.5, 10, 20, or 40 mg once daily has shown favorable results on exercise capacity, symptoms, hemodynamics, and time to clinical worsening at the highest dose (44). The side effect profile was similar to that of sildenafil. Tadalafil is an oral PDE-5 inhibitor with longer half-life than sildenafil so that it requires once daily administration.

8.2 Lactation

Most patients will be better suited to try one drug for a couple of weeks and then switch to the other for another couple of weeks to see which has a better function and side effect profile. From then on, patients can enjoy the low cost of generic tablets while still getting the same benefit. Marketing ED medications and various formulations and options is a billion-dollar business with plenty of misunderstandings that must be corrected. Ultimately, patients should speak to a qualified men’s health urologist to understand more about the cause of their ED and their best treatment options. Newfangled ED medication options like combination therapy may be marketed as effective, but ultimately, they may be a waste of money.

What is the best time to take tadalafil daily?

We encourage you to contact tadalafil daily our office to learn more. Tadalafil is defined as an oral PDE-5 inhibitor that has a longer half-life than sildenafil, allowing for once daily administration. It is used in the treatment of conditions such as pulmonary arterial hypertension, showing small improvements in portal venous and pulmonary artery pressures. Tadalafil is a newer, longer-acting PDE5 inhibitor. A recent 16-week RCT included patients with IPAH and PAH associated with connective tissue disease, congenital heart disease, and HIV who were randomized to placebo or tadalafil 2.5 mg, 10 mg, 20 mg, or 40 mg orally once daily.46 Treatment was given as monotherapy, or, in 53% of patients, as add-on therapy to bosentan.

Postmarketing reports

Tadalafil 40 mg increased 6-minute walk distance and quality of life, delayed the time to clinical worsening, and improved hemodynamics. The most common treatment-related adverse event reported with tadalafil was headache. Tadalafil is a once daily dispensed, selective PDE-5i. An RCT (PHIRST [Pulmonary arterial Hypertension and ReSponse to Tadalafil] trial) in 406 PAH patients (53% on background bosentan therapy) treated with tadalafil 2.5, 10, 20, or 40 mg once daily has shown favorable results on exercise capacity, symptoms, hemodynamics, and time to clinical worsening at the highest dose (44). The side effect profile was similar to that of sildenafil. To date, only one case describing treatment of PoPH has been reported that showed a small improvement in portal venous and pulmonary artery pressures [67]. We believe that the role for tadalafil in the treatment of PoPH is similar to that of sildenafil. In a single randomized placebo-controlled study 10 HAPE-susceptible subjects received tadalafil 10 mg twice daily during a rapid ascent to 4559 m [86]. Two of the subjects receiving tadalafil withdrew from the study due to severe AMS on arrival at 4559 m, although they did not have HAPE prior to descent. Only 1 of the remaining 8 subjects who received tadalafil developed HAPE. In the placebo group, 7 of 9 subjects developed HAPE. The occurrence of AMS with tadalifil may have discouraged further trials as well as the accumulation of any clinical experience using tadalafil in the prevention of HAPE.

• Tadalafil 40mg is a potent PDE5 inhibitor used for specific medical needs.
• Check expiration date before using to ensure medication efficacy.
• Avoid taking Tadalafil 40mg with fatty meals if concerned about absorption.
• Lifestyle modifications can enhance the effectiveness of Tadalafil treatment.
• Combination therapy with other ED drugs is not usually recommended.
• Contact emergency services if you experience symptoms of a heart attack.

Tadalafil cannot be recommended to prevent HAPE in the absence of further study. Tadalafil is a selective PDE5-inhibitor that can be administered once daily. Its beneficial effects in adults with PAH, consisting of improved exercise capacity, haemodynamics and time to clinical worsening, have been demonstrated in a recent pivotal RCT (PHIRST-1). Patients were at least 12 years old, however the median age was 54 ± 15 years. Tadalafil was well tolerated, side-effects reported were headache, myalgia and flushing.53 No specific data concerning tadalafil in children with PAH are available.

2.1 Pulmonary Arterial Hypertension

From online ED medication sellers to major e-commerce platforms, everyone is getting in on the ED med game. However, it’s important to understand what represents tried and true, gold standard treatment and what may be hyped to sell a more expensive product. One such question revolves around a relatively new phenomenon – combining Tadalafil, the generic of Cialis, and sildenafil, the generic of Viagra, into a single-dose tablet, chewable, or sublingual tab. If you search online, many ED med sellers are now touting this as an effective alternative to single medication therapy. The short answer is that both sildenafil and tadalafil are phosphodiesterase-5 (PDE-5) inhibitors and work similarly.

Tadalafil for Prostate Cancer

To that end, it’s unlikely there will be any substantial difference between a single and dual medication therapy. From a urologist’s perspective, the dual medication option is a slick marketing tool to introduce a new medication option while creating a compoundable option that circumvents the limitations associated with marketing and selling generic drugs. While most patients will not have adverse effects with an appropriate combination of medical therapy, there can be potential concerns. For sildenafil, the max dose is 100 mg, while tadalafil’s max dose is 20 mg. It’s vital that, in combination, these two drugs do not cause patients to overdose.

What should I do for a missed dose of tadalafil?

With different dosages and time of action, knowing precisely what proportion of each medication should be taken can be challenging. Some unscrupulous compounding pharmacies and online purveyors may not regulate how much of each drug they use. A second practical consideration for most patients is that each drug has a somewhat different side effect profile. By taking a combination of drugs, patients are increasing their risk of experiencing a side effect – they are now subjected to the risk profile of two drugs rather than just one. Combination drug therapy tends to be more expensive than standard generic tablets. Tadalafil, a carboline derivative with vasodilatory activity, selectively inhibits cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). During sexual stimulation, nitric oxide (NO) produced and released from nerves and endothelial cells, stimulates soluble guanylate cyclase and initiates the production of the messenger cGMP in the corpus cavernosum smooth muscles. PDE5 is important in regulating intracellular concentrations of cGMP by catalyzing its hydrolysis and inactivating cGMP. The inhibition of PDE5 by tadalafil increases the cGMP level in the corpus cavernosum. As a result, prolonged smooth muscle relaxation occurs together with vasodilation of the corpus cavernosum, leading to penile erection (Carrier, 2003). Tadalafil has no effect in the absence of sexual stimulation. In addition, tadalafil is also used to treat benign prostatic hyperplasia (BPH) and pulmonary arterial hypertension (Croxtall and Lyseng-Williamson, 2010). Tadalafil preserves the concentration of cGMP, thus promoting vasodilation in corpus cavernosum and pulmonary vasculature. Tadalafil is rapidly absorbed after oral administration. Compared with other PDE5 inhibitors used in treating erectile dysfunction, tadalafil has the longest duration of action, making it the only once-daily agent of all PDE5 inhibitors. Tadalafil is a phosphodiesterase-5 (PDE-5) inhibitor that was tadalafil over the counter uk approved by the US Food and Drug Administration (FDA) in 2009 for the treatment of pulmonary arterial hypertension (PAH). The purpose of this review is to evaluate the pharmacology, pharmacokinetic properties, clinical efficacy, adverse effects, drug interactions, and dosage and administration of tadalafil in patients with PAH. A literature search of MEDLINE and International Pharmaceutical Abstracts (1960 through September 5, 2010) was conducted with the search terms tadalafil, pulmonary arterial hypertension, and phosphodiesterase-5 inhibitor. Data found from orignial research and case series published in English were screened for relevancy to pharmacology, pharmacokinetics, clinical efficacy and safety, and tolerability. Relevant articles from the bibliographies of the identified published articles were also obtained. Unpublished data and posters were obtained from the manufacturer of tadalafil and the FDA Web site. By selectively inhibiting PDE-5, tadalafil causes nitric oxide–mediated vasodilation in the pulmonary vasculature. Tadalafil has a greater affinity (10,000-fold) for PDE-5 compared with the other PDE inhibitors and has a t½ of 17.5 hours. In a controlled clinical study in patients with PAH, patients receiving tadalafil in a total daily dose of 40 mg had significant improvements in their 6-minute walk distance (33 m from baseline) and time to clinical worsening compared with those receiving placebo (both, P < 0.05).

7.4 Alcohol

Tadalafil has a greater affinity (10,000-fold) for PDE-5 compared with the other PDE inhibitors and has a t½ of 17.5 hours. In a controlled clinical study in patients with PAH, patients receiving tadalafil in a total daily dose of 40 mg had significant improvements in their 6-minute walk distance (33 m from baseline) and time to clinical worsening compared with those receiving placebo (both, P < 0.05). Tadalafil had adverse effects similar to placebo, with headache being the most commonly reported (42%). In the small number of studies available, tadalafil was effective and well tolerated when used to treat patients with PAH. Compared with placebo, tadalafil was associated with significant improvements in exercise capacity and reduced time to clinical worsening (68% relative risk reduction; P = 0.038). Tadalafil had adverse effects similar to placebo, with headache being the most commonly reported (42%). In the small number of studies available, tadalafil was effective and well tolerated when used to treat patients with PAH.

Important Safety Information for ambrisentan and tadalafil in the European Union

There is limited evidence comparing tadalafil with sildenafil and vardenafil, and the studies are limited by short treatment durations. Tadalafil is a beta-carboline–based PDE5 inhibitor that was designed to inhibit PDE activity and to have high specificity for PDE5. The selectivity of tadalafil for PDE5 is reported to be 9000-fold to 10,000-fold greater than for PDE1 to PDE4 and PDE7 to PDE1069and package insert and to be nearly 800-fold greater for PDE5 than for PDE6.69 The clinical efficacy of tadalafil as a PDE5 inhibitor has been well shown in studies of ED and seems to be at least as effective as other PDE5 inhibitors.70 Following successful reports of sildenafil for the treatment of PAH, several preliminary studies reported similar efficacy for this indication with tadalafil. The longer half-life of tadalafil, which allowed once-daily dosing, also made it an attractive alternative to sildenafil for the long-term treatment of PAH. In 2004, Ghofrani and colleagues71 compared the acute vasodilator effects of 3 PDE5 inhibitors in 60 consecutive patients as part of their initial evaluation of pulmonary hypertension. Compared with placebo, tadalafil was associated with significant improvements in exercise capacity and reduced time to clinical worsening (68% relative risk reduction; P = 0.038). There is limited evidence comparing tadalafil with sildenafil and vardenafil, and the studies are limited by short treatment durations. Tadalafil is a beta-carboline–based PDE5 inhibitor that was designed to inhibit PDE activity and to have high specificity for PDE5. The selectivity of tadalafil for PDE5 is reported to be 9000-fold to 10,000-fold greater than for PDE1 to PDE4 and PDE7 to PDE1069and package insert and to be nearly 800-fold greater for PDE5 than for PDE6.69 The clinical efficacy of tadalafil as a PDE5 inhibitor has been well shown in studies of ED and seems to be at least as effective as other PDE5 inhibitors.70 Following successful reports of sildenafil for the treatment of PAH, several preliminary studies reported similar efficacy for this indication with tadalafil. The longer half-life of tadalafil, which allowed once-daily dosing, also made it an attractive alternative to sildenafil for the long-term treatment of PAH. In 2004, Ghofrani and colleagues71 compared the acute vasodilator effects of 3 PDE5 inhibitors in 60 consecutive patients as part of their initial evaluation of pulmonary hypertension.

• Tadalafil 40mg is effective for both erectile dysfunction and BPH symptoms.
• It is important to hydrate well when using this medication.
• Avoid grapefruit or grapefruit juice when taking Tadalafil 40mg.
• Do not use Tadalafil 40mg if you are allergic to similar medications.
• Monitor blood pressure regularly during Tadalafil therapy.
• Side effects tend to be mild but consult a doctor if severe.